Wall Street JournalAmgen Profit Rises 17%, Guidance RaisedWall Street JournalAmgen Inc. AMGN -0.27 % said its first-quarter earnings rose 17% on better-than expected revenue, again boosted by sales of key drugs such as Enbrel, and osteoporosis therapies Xgeva and Prolia. The Thousand Oaks, Calif., biotechnology company again ...UPDATE 1-Amgen profit sails past Street expectations; raises 2016 outlookReutersAmgen Posts 1Q Sales, Profit Jumps, Raises Profit ForecastsNew York TimesTrade-Ideas: Amgen (AMGN) Is Today's Post-Market Leader StockTheStreet.comBloomberg -Zacks.com -Benzinga -Market Digestall 29 news articles »